Xencor Inc (XNCR) Stock Analysis

Xencor Inc (XNCR) is a publicly traded company in the HEALTHCARE sector. It trades at $11.21, carries a market capitalization of $874.87M. This page summarizes the public market data, fundamentals, and frequently asked questions for XNCR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Xencor Inc currently has a Neutral sentiment score of -0.04.

About Xencor Inc

Xencor, Inc. is a clinical-stage biopharmaceutical company based in Monrovia, California, focused on the development of advanced cytokine and monoclonal antibody therapies targeting unmet medical needs in oncology and autoimmune disorders. Utilizing its proprietary XmAb technology platform, Xencor aims to improve therapeutic efficacy and safety, offering promising solutions to complex health challenges. With a strong and diverse pipeline poised for clinical advancement, Xencor is well-positio...

GNG Research Analysis

GNG Research scores Xencor Inc (XNCR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for XNCR.

Frequently Asked Questions

Does XNCR pay dividends?

Xencor Inc (XNCR) does not currently pay a regular dividend.

What is XNCR's market cap?

Xencor Inc (XNCR) has a market capitalization of $874.87M with a current stock price of $11.21.